<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30447245</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0984</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of virological methods</Title><ISOAbbreviation>J Virol Methods</ISOAbbreviation></Journal><ArticleTitle>Deep sequencing prompts the modification of a real-time RT-PCR for the serotype-specific detection of polioviruses.</ArticleTitle><Pagination><StartPage>38</StartPage><EndPage>43</EndPage><MedlinePgn>38-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jviromet.2018.11.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0166-0934(18)30367-7</ELocationID><Abstract><AbstractText>Polioviruses are members of the Enterovirus C species and asymptomatic fecal shedding allows for their transmission and persistence in a community, as well as the emergence of vaccine-derived polioviruses. Using three serotype-specific real-time RT-PCR (rRT-PCR) assays, the shedding and circulation of oral poliovirus vaccine (OPV) strains was previously investigated in a prospective cohort of Mexican children, their contacts, and nearby sewage. Subsequently, a deep sequencing approach targeting the P1 genomic region was applied to characterize OPV strains previously detected by rRT-PCR. Amplifiable RNA was obtained for sequencing from 40.3% (58/144) of stool samples and 71.4% (15/21) of sewage using nucleic acids extracted directly from primary rRT-PCR-positive specimens. Sequencing detected one or more OPV serotypes in 62.1% (36/58) of stool and 53.3% (8/15) of sewage samples. All stool and sewage samples in which poliovirus was not detected by deep sequencing contained at least one non-polio enterovirus C (NPEV-C) strain. To improve screening specificity, a modified, two-step, OPV serotype-specific multiplex rRT-PCR was evaluated. In stool specimens, the overall agreement between the original assays and the multiplex was 70.3%. By serotype, the overall agreement was 95.7% for OPV serotype-1 (S1), 65.6% for S2, and 96.1% for S3. Furthermore, most original rRT-PCR positive/multiplex rRT-PCR negative results were collected in the summer and fall months, consistent with NPEV-C circulation patterns. In conclusion, this deep sequencing approach allowed for the characterization of OPV sequences directly from clinical samples and facilitated the implementation of a more specific multiplex rRT-PCR for OPV detection and serotyping.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Holubar</LastName><ForeName>Marisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahoo</LastName><ForeName>Malaya K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>ChunHong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed-Hadley</LastName><ForeName>Alisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waggoner</LastName><ForeName>Jesse J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troy</LastName><ForeName>Stephanie B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Eastern Virginia Medical School, Norfolk, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Garc&#xed;a</LastName><ForeName>Lourdes</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica, Cuernavaca, Morelos, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreyra-Reyes</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica, Cuernavaca, Morelos, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maldonado</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinsky</LastName><ForeName>Benjamin A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States; Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States. Electronic address: bpinsky@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AI052073</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Virol Methods</MedlineTA><NlmUniqueID>8005839</NlmUniqueID><ISSNLinking>0166-0934</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012722">Sewage</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D030015" MajorTopicYN="N">Enterovirus C, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="Y">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012722" MajorTopicYN="N">Sewage</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus c human</Keyword><Keyword MajorTopicYN="N">High-throughput nucleotide sequencing</Keyword><Keyword MajorTopicYN="N">Poliovirus</Keyword><Keyword MajorTopicYN="N">Poliovirus vaccine oral</Keyword><Keyword MajorTopicYN="N">Real-time polymerase chain reaction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30447245</ArticleId><ArticleId IdType="pmc">PMC6320388</ArticleId><ArticleId IdType="doi">10.1016/j.jviromet.2018.11.007</ArticleId><ArticleId IdType="pii">S0166-0934(18)30367-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morales M., Tangermann R.H., Wassilak S.G. Progress toward polio eradication - worldwide, 2015-2016. MMWR Morb. Mortal. Wkly. Rep. 2016;65(18):470&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">27171208</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative Global Eradication of Wild Poliovirus Type 2 Declared. http://www.polioeradication.org/%20mediaroom/newsstories/Global-eradication-of-wild-poliovirus-type-2-declared/tabid/526/news/1289/Default.aspx Available at: Accessed August 14.</Citation></Reference><Reference><Citation>Kew O.M., Cochi S.L., Jafari H.S. Possible eradication of wild poliovirus type 3--worldwide. MMWR Morb. Mortal. Wkly. Rep. 2012;63(45):1031&#x2013;1033. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5779498</ArticleId><ArticleId IdType="pubmed">25393222</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales M., Nnadi C.D., Tangermann R.H., Wassilak S.G. Notes from the field: circulating vaccine-derived poliovirus outbreaks - five countries, 2014-2015. MMWR Morb. Mortal. Wkly. Rep. 2016;65(5):128&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">26866942</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C., Wadood Z.M., Moran T. Strategic response to an outbreak of circulating vaccine-derived poliovirus type 2 - Syria, 2017-2018. MMWR Morb. Mortal. Wkly. Rep. 2018;67(24):690&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6013082</ArticleId><ArticleId IdType="pubmed">29927908</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman M.M., Chitale R., Burns C.C. Vaccine-derived poliovirus outbreaks and events - three provinces, Democratic Republic of the Congo. MMWR Morb. Mortal. Wkly. Rep. 2018. 2017;67(10):300&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5857197</ArticleId><ArticleId IdType="pubmed">29543791</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutter R.W., Kew O.M., Cochi S.L. In: Aylward RB. 28 - Poliovirus Vaccine&#x2014;Live A2 - Plotkin, Stanley A. sixth edition. Orenstein W.A., Vaccines Offit P.A., editors. W.B. Saunders; London: 2013. pp. 598&#x2013;645.</Citation></Reference><Reference><Citation>Benyesh-Melnick M., Melnick J.L., Rawls W.E. Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter. Am. J. Epidemiol. 1967;86(1):112&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">4378110</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasher D., Rahav G., Levine H. How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience. Vaccine. 2016;34(3):299&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">26679402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnanashanmugam D., Falkovitz-Halpern M.S., Dodge A. Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay. J. Clin. Microbiol. 2007;45(8):2419&#x2013;2425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951214</ArticleId><ArticleId IdType="pubmed">17581940</ArticleId></ArticleIdList></Reference><Reference><Citation>Troy S.B., Ferreyra-Reyes L., Huang C. Use of a novel real-time PCR assay to detect oral polio vaccine shedding and reversion in stool and sewage samples after a mexican national immunization day. J. Clin. Microbiol. 2011;49(5):1777&#x2013;1783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3122635</ArticleId><ArticleId IdType="pubmed">21411577</ArticleId></ArticleIdList></Reference><Reference><Citation>Troy S.B., Ferreyra-Reyes L., Huang C. Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks. J. Infect. Dis. 2014;209(11):1693&#x2013;1699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4017366</ArticleId><ArticleId IdType="pubmed">24367038</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo M.K., Holubar M., Huang C. Detection of emerging vaccine-related polioviruses by deep sequencing. J. Clin. Microbiol. 2017;55(7):2162&#x2013;2171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5483918</ArticleId><ArticleId IdType="pubmed">28468861</ArticleId></ArticleIdList></Reference><Reference><Citation>Troy S.B., Ferreyra-Reyes L., Canizales-Quintero S. Real-time polymerase chain reaction analysis of sewage samples to determine oral polio vaccine circulation duration and mutation after mexican national immunization weeks. J. Pediatric Infect. Dis. Soc. 2012;1(3):223&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3529100</ArticleId><ArticleId IdType="pubmed">23667738</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov K.M. PCR engineering of viral quasispecies: a new method to preserve and manipulate genetic diversity of RNA virus populations. J. Virol. 1996;70(10):7331&#x2013;7334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190799</ArticleId><ArticleId IdType="pubmed">8794393</ArticleId></ArticleIdList></Reference><Reference><Citation>Neverov A., Chumakov K. Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccines. Proc. Natl. Acad. Sci. U. S. A. 2010;107(46):20063&#x2013;20068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2993378</ArticleId><ArticleId IdType="pubmed">21041640</ArticleId></ArticleIdList></Reference><Reference><Citation>Boot H.J., Schepp R.M., van Nunen F.J., Kimman T.G. Rapid RT-PCR amplification of full-length poliovirus genomes allows rapid discrimination between wild-type and recombinant vaccine-derived polioviruses. J. Virol. Methods. 2004;116(1):35&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">14715305</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England) 2010;26(5):589&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2828108</ArticleId><ArticleId IdType="pubmed">20080505</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne I., Stephen G., Bayer M. Using Tablet for visual exploration of second-generation sequencing data. Brief Bioinform. 2013;14(2):193&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">22445902</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Kalscheuer V., Tzschach A. Mapping translocation breakpoints by next-generation sequencing. Genome Res. 2008;18(7):1143&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2493403</ArticleId><ArticleId IdType="pubmed">18326688</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick D.R., Yang C.F., Ching K. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J. Clin. Microbiol. 2009;47(6):1939&#x2013;1941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2691077</ArticleId><ArticleId IdType="pubmed">19386844</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniuchi M., Begum S., Uddin M.J. Kinetics of poliovirus shedding following oral vaccination as measured by quantitative reverse transcription-PCR versus culture. J. Clin. Microbiol. 2015;53(1):206&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4290924</ArticleId><ArticleId IdType="pubmed">25378579</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Leer-Buter C.C., Poelman R., Borger R. Niesters HG. Newly identified enterovirus C genotypes, identified in the Netherlands through routine sequencing of all enteroviruses detected in clinical materials from 2008 to 2015. J. Clin. Microbiol. 2016;54(9):2306&#x2013;2314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5005491</ArticleId><ArticleId IdType="pubmed">27358467</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M., Parker E.P., Grassly N.C. The epidemiology of non-polio enteroviruses: recent advances and outstanding questions. Curr. Opin. Infect. Dis. 2015;28(5):479&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6624138</ArticleId><ArticleId IdType="pubmed">26203854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreyra-Reyes L., Cruz-Hervert L.P., Troy S.B. Assessing the individual risk of fecal poliovirus shedding among vaccinated and non-vaccinated subjects following national health weeks in Mexico. PLoS One. 2017;12(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5638237</ArticleId><ArticleId IdType="pubmed">29023555</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns C.C., Diop O.M., Sutter R.W., Kew O.M. Vaccine-derived polioviruses. J. Infect. Dis. 2014;210(Suppl. 1):S283&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew O.M., Sutter R.W., de Gourville E.M., Dowdle W.R., Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 2005;59:587&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">16153180</ArticleId></ArticleIdList></Reference><Reference><Citation>Jegouic S., Joffret M.L., Blanchard C. Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses. PLoS Pathog. 2009;5(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2669712</ArticleId><ArticleId IdType="pubmed">19412342</ArticleId></ArticleIdList></Reference><Reference><Citation>Riquet F.B., Blanchard C., Jegouic S. Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus. J. Virol. 2008;82(17):8927&#x2013;8932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2519664</ArticleId><ArticleId IdType="pubmed">18579607</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>